Dinesh Kumar,Saurabh Srivastava,Indranil Nandi,Rakesh K. Singh,Amit Jha,Kamal S. Mehta
申请号：
US16828858
公开号：
US20200222421A1
申请日:
2020.03.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention discloses an extended release oral liquid pharmaceutical composition comprising eslicarbazepine or its pharmaceutically acceptable esters, salts, solvates, polymorphs, enantiomers or mixtures thereof in a pharmaceutically acceptable carrier. The extended release liquid compositions are in the form of ready-to-use liquid compositions or reconstituted liquid compositions. It also relates to processes for the preparation of said extended release liquid compositions. The prior art discloses immediate release oral liquid dosage form. The prepared novel test formulations exhibited desired pharmaceutical technical attributes.
